Version 2 of 5 (1997-01-22 to 1998-01-02) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
Corporation: |
ASTRAZENECA CANADA INC.
1004 MIDDLEGATE ROAD MISSISSAUGA, ON L5B 1M4 Canada |
Telephone number: | 905-277-7111 |
Fax number: | 905-270-3248 |
Responsible officer name and position during the period of this registration: | MURRAY A. BROWN, EXECUTIVE DIRECTOR, GOVERNMENT AFFAIRS |
Description of activities: | RESEARCH, DEVELOPMENT, SALES AND MARKETING OF PATENTED HUMAN PHARMACEUTICAL PRODUCTS. |
Parent: | The corporation is not a subsidiary of any other parent corporations. |
Coalition | The corporation is not a member of a coalition. |
Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Aboriginal Affairs and Northern Development Canada, Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada, National Defence (DND), Patented Medicine Prices Review Board (PMPRB) |
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format |
Subject Matter: Areas of Concern: | Health, Industry, Intellectual Property, Internal Trade, Science and Technology |
Subject Matter: Particulars: | LOBBYING & ADVOCATING COMPANY POSITIONS ON POLICIES REGULATIONS & STATUTES CONCERNING HEALTH /INTELLECTUAL PROPERTY PROTECTION/ TRADE & EXPORT. PARLIAMENTARY REVIEW C-91 [ DRUG PATENTS] ONGOING DISCUSSIONS OF REGULATIONS WITH HEALTH PROTECTION BRANCH RELATED TO ISSUES AFFECTING MARKET ACCESS. |